Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HLN · against 1,216 other Healthcare companies
Ranked #774 of 1,217 · scores higher than 36% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 30–39, including HLN · Click a bar to see the companies
Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | HLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -1.8% | 6.1% | 27% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 17.3% | 9.7% | 59% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 0.5% | 5.8% | 30% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 774 | 101.2B JPY (≈$688M) | 36 | 54 | |
| 774 | 9.9B HKD (≈$1.3B) | 36 | 17 | |
| 774 | 1.1B NOK (≈$105M) | 36 | 58 | |
| 774 | 3.0B USD | 36 | 35 | |
| 774 | 38.9B USD | 36 | 56 | |
| 774 | 2.6B USD | 36 | 32 | |
| 774 | 5.9B USD | 36 | 39 | |
| 786 | 4.4B CNY (≈$611M) | 35 | 77 | |
| 786 | 28.4B CNY (≈$4.0B) | 35 | 62 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score